Precision medicine is an emerging field that looks at how a person’s unique genetic makeup can help determine what treatment might work best for that individual.  Although many research studies have shown that precision medicine can lead to better health for some patients, very few of these research studies have looked at precision medicine specifically for African Americans.  As a result, we don’t know if African Americans benefit from precision medicine as much as people of European ancestry do.

Founded in 2016, the African American Cardiovascular pharmacogenetics CONsorTium, or ACCOuNT, is a group of doctors, researchers, community leaders, and patients whose goal is to ensure that all people, including African Americans, benefit equally from precision medicine.

Learn more about ACCOuNT and its leaders: